Read + Share
Passaro A, Mok T, Peters S, Popat S, et al. Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management
of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations. J Thorac Oncol 2021;16:764-773.
PMID: 33333327
|
 |
|
Passaro A, Mok T, Peters S, Popat S, et al. Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management
of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations. J Thorac Oncol 2021;16:764-773.
PMID: 33333327
|
|
|
|